{{Rsnum
|rsid=3850370
|Chromosome=14
|position=78068563
|Orientation=plus
|GMAF=0.3163
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 6.2 | 37.2 | 56.6
| HCB | 5.8 | 40.9 | 53.3
| JPT | 11.5 | 39.8 | 48.7
| YRI | 28.6 | 49.7 | 21.8
| ASW | 19.3 | 49.1 | 31.6
| CHB | 5.8 | 40.9 | 53.3
| CHD | 10.1 | 36.7 | 53.2
| GIH | 8.9 | 52.5 | 38.6
| LWK | 35.5 | 52.7 | 11.8
| MEX | 5.2 | 32.8 | 62.1
| MKK | 21.8 | 51.3 | 26.9
| TSI | 6.9 | 27.5 | 65.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22872573
  |Trait=Response to platinum-based chemotherapy in non-small-cell lung cancer
  |Title=Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.
  |RiskAllele=C
  |Pval=4E-6
  |OR=1.31
  |ORtxt=[1.17-1.47]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}